Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners
Tribe Technology set to deliver healthy pipeline of orders from Tier-One minersView Video
Andrada Mining acquisition elevates the miner to emerging mid-tier status
Andrada Mining acquisition elevates the miner to emerging mid-tier statusView Video

Latest Share Chat

Tuesday broker round-up

Tue, 15th Mar 2016 16:46

(ShareCast News) - Virgin Money: Goldman Sachs reiterates neutral with a target price of 450p and Berenberg stays at hold with a 400p target.Gem Diamonds: Panmure Gordon keeps at buy, 181p target and Finncap reiterates buy with a target of 270p.G4S: Credit Suisse reiterates neutral with a target price of 200p and Citigroup stays at neutral with a target price of 190p.Inmarsat: HSBC stays at hold with a target price of 980p and Credit Suisse reiterates outperform with a target price of 1186p.Wood Group: Canaccord downgrades to sell a target of 575p.RBS: Goldman Sachs upgrades to buy with a target price of 375p.3i Group: Canaccord starts coverage at buy, 595p target.Anglo American: Morgan Stanley reiterates underweight with a target price of 420p.Astrazeneca: Jefferies maintains hold with a 4350p target.Barclays: Berenberg keeps at hold and with a target of 170p.HSBC: Berenberg reiterates buy, 600p target.

Related Shares

More News
27 Jun 2024 13:00

German vaccine panel endorses Astra-Sanofi's RSV shot for infants

FRANKFURT, June 27 (Reuters) - Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca a...

26 Jun 2024 08:40

TOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in China

(Alliance News) - AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day after a similar...

25 Jun 2024 09:05

TOP NEWS: AstraZeneca details mixed findings from cancer drug trials

(Alliance News) - AstraZeneca PLC on Tuesday announced a mixed bag of results for two of its leading cancer drugs Imfinzi and Tagrisso.

25 Jun 2024 07:48

LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake

(Alliance News) - London's FTSE 100 is set to tread water on Tuesday, with a slump for US tech shares overnight keeping a lid on enthusiasm.

25 Jun 2024 07:17

AstraZeneca posts mixed results from recent Imfinzi trials

(Sharecast News) - AstraZeneca announced contrasting results from two phase three trials involving its immunotherapy drug 'Imfinzi', or durvalumab, on...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.